These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36706955)

  • 1. Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort.
    Matveyenko A; Matienzo N; Ginsberg H; Nandakumar R; Seid H; Ramakrishnan R; Holleran S; Thomas T; Reyes-Soffer G
    J Lipid Res; 2023 Mar; 64(3):100336. PubMed ID: 36706955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
    Chan DC; Watts GF; Coll B; Wasserman SM; Marcovina SM; Barrett PHR
    J Am Heart Assoc; 2019 Apr; 8(7):e011781. PubMed ID: 30897995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
    Blanchard V; Chemello K; Hollstein T; Hong-Fong CC; Schumann F; Grenkowitz T; Nativel B; Coassin S; Croyal M; Kassner U; Lamina C; Steinhagen-Thiessen E; Lambert G
    Cardiovasc Res; 2022 Jul; 118(9):2103-2111. PubMed ID: 34314498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
    Tsimikas S; Clopton P; Brilakis ES; Marcovina SM; Khera A; Miller ER; de Lemos JA; Witztum JL
    Circulation; 2009 Apr; 119(13):1711-9. PubMed ID: 19307470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ; Cain W; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1993 Feb; 91(2):443-7. PubMed ID: 8432853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
    Hopewell JC; Seedorf U; Farrall M; Parish S; Kyriakou T; Goel A; Hamsten A; Collins R; Watkins H; Clarke R;
    J Intern Med; 2014 Sep; 276(3):260-8. PubMed ID: 24372611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration.
    Ma L; Chan DC; Ooi EMM; Marcovina SM; Barrett PHR; Watts GF
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6247-6255. PubMed ID: 31393573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians.
    Valenti K; Aveynier E; Leauté S; Laporte F; Hadjian AJ
    Atherosclerosis; 1999 Nov; 147(1):17-24. PubMed ID: 10525120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect.
    Gaw A; Brown EA; Ford I
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1870-6. PubMed ID: 9848878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentration.
    Ying Q; Chan DC; Pang J; Marcovina SM; Barrett PHR; Watts GF
    J Intern Med; 2022 Jun; 291(6):870-876. PubMed ID: 35112754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant differentiation in the apolipoprotein(a)/lipoprotein(a) trait between chimpanzees from Western and Central Africa.
    Noureen A; Ronke C; Khalifa M; Halbwax M; Fischer A; André C; Atencia R; Garriga R; Mugisha L; Ceglarek U; Thiery J; Utermann G; Schmidt K
    Am J Primatol; 2017 Sep; 79(9):. PubMed ID: 28671714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a).
    Watts GF; Chan DC; Pang J; Ma L; Ying Q; Aggarwal S; Marcovina SM; Barrett PHR
    Metabolism; 2020 Jun; 107():154221. PubMed ID: 32240727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different apoprotein(a) isoform proportions in serum and carotid plaque.
    Baldo G; Giunco S; Kontothanassis D; Baiocchi MR; Valerio A; Frego M
    Atherosclerosis; 2007 Jul; 193(1):177-85. PubMed ID: 16839560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
    Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
    Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.